333 related articles for article (PubMed ID: 22467657)
21. CD163-L1 is an endocytic macrophage protein strongly regulated by mediators in the inflammatory response.
Moeller JB; Nielsen MJ; Reichhardt MP; Schlosser A; Sorensen GL; Nielsen O; Tornøe I; Grønlund J; Nielsen ME; Jørgensen JS; Jensen ON; Mollenhauer J; Moestrup SK; Holmskov U
J Immunol; 2012 Mar; 188(5):2399-409. PubMed ID: 22279103
[TBL] [Abstract][Full Text] [Related]
22. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
[TBL] [Abstract][Full Text] [Related]
23. Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs.
Ando M; Tu W; Nishijima K; Iijima S
Biochem Biophys Res Commun; 2008 May; 369(3):878-83. PubMed ID: 18325328
[TBL] [Abstract][Full Text] [Related]
24. Human-specific expression of Siglec-6 in the placenta.
Brinkman-Van der Linden EC; Hurtado-Ziola N; Hayakawa T; Wiggleton L; Benirschke K; Varki A; Varki N
Glycobiology; 2007 Sep; 17(9):922-31. PubMed ID: 17580316
[TBL] [Abstract][Full Text] [Related]
25. Colonic epithelial cell expression of ICAM-1 relates to loss of surface continuity: a comparative study of inflammatory bowel disease and colonic neoplasms.
Vainer B; Horn T; Nielsen OH
Scand J Gastroenterol; 2006 Mar; 41(3):318-25. PubMed ID: 16497620
[TBL] [Abstract][Full Text] [Related]
26. Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells.
Kawasaki Y; Ito A; Withers DA; Taima T; Kakoi N; Saito S; Arai Y
Glycobiology; 2010 Nov; 20(11):1373-9. PubMed ID: 20663960
[TBL] [Abstract][Full Text] [Related]
27. Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy.
Baeten D; Demetter P; Cuvelier CA; Kruithof E; Van Damme N; De Vos M; Veys EM; De Keyser F
J Pathol; 2002 Mar; 196(3):343-50. PubMed ID: 11857499
[TBL] [Abstract][Full Text] [Related]
28. Siglecs in innate immunity.
Crocker PR
Curr Opin Pharmacol; 2005 Aug; 5(4):431-7. PubMed ID: 15955740
[TBL] [Abstract][Full Text] [Related]
29. Deletion polymorphism of SIGLEC14 and its functional implications.
Yamanaka M; Kato Y; Angata T; Narimatsu H
Glycobiology; 2009 Aug; 19(8):841-6. PubMed ID: 19369701
[TBL] [Abstract][Full Text] [Related]
30. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model.
Matsumoto S; Hara T; Mitsuyama K; Yamamoto M; Tsuruta O; Sata M; Scheller J; Rose-John S; Kado S; Takada T
J Immunol; 2010 Feb; 184(3):1543-51. PubMed ID: 20042582
[TBL] [Abstract][Full Text] [Related]
31. Constitutively expressed Siglec-9 inhibits LPS-induced CCR7, but enhances IL-4-induced CD200R expression in human macrophages.
Higuchi H; Shoji T; Iijima S; Nishijima K
Biosci Biotechnol Biochem; 2016 Jun; 80(6):1141-8. PubMed ID: 26923638
[TBL] [Abstract][Full Text] [Related]
32. Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells.
Yu Y; Blokhuis BRJ; Diks MAP; Keshavarzian A; Garssen J; Redegeld FA
Front Immunol; 2018; 9():2138. PubMed ID: 30294327
[TBL] [Abstract][Full Text] [Related]
33. Isolation and phenotypic characterization of colonic macrophages.
Rogler G; Hausmann M; Vogl D; Aschenbrenner E; Andus T; Falk W; Andreesen R; Schölmerich J; Gross V
Clin Exp Immunol; 1998 May; 112(2):205-15. PubMed ID: 9649182
[TBL] [Abstract][Full Text] [Related]
34. The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis.
Xiao H; Gulen MF; Qin J; Yao J; Bulek K; Kish D; Altuntas CZ; Wald D; Ma C; Zhou H; Tuohy VK; Fairchild RL; de la Motte C; Cua D; Vallance BA; Li X
Immunity; 2007 Apr; 26(4):461-75. PubMed ID: 17398123
[TBL] [Abstract][Full Text] [Related]
35. Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates.
Angata T; Hayakawa T; Yamanaka M; Varki A; Nakamura M
FASEB J; 2006 Oct; 20(12):1964-73. PubMed ID: 17012248
[TBL] [Abstract][Full Text] [Related]
36. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
Cao H; Crocker PR
Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
[TBL] [Abstract][Full Text] [Related]
37. Comparative assessment of the recognition of domain-specific CD163 monoclonal antibodies in human monocytes explains wide discrepancy in reported levels of cellular surface CD163 expression.
Maniecki MB; Etzerodt A; Moestrup SK; Møller HJ; Graversen JH
Immunobiology; 2011 Aug; 216(8):882-90. PubMed ID: 21458881
[TBL] [Abstract][Full Text] [Related]
38. Immunomodulatory activity of extracellular Hsp70 mediated via paired receptors Siglec-5 and Siglec-14.
Fong JJ; Sreedhara K; Deng L; Varki NM; Angata T; Liu Q; Nizet V; Varki A
EMBO J; 2015 Nov; 34(22):2775-88. PubMed ID: 26459514
[TBL] [Abstract][Full Text] [Related]
39. A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing.
Hernández-Caselles T; Martínez-Esparza M; Pérez-Oliva AB; Quintanilla-Cecconi AM; García-Alonso A; Alvarez-López DM; García-Peñarrubia P
J Leukoc Biol; 2006 Jan; 79(1):46-58. PubMed ID: 16380601
[TBL] [Abstract][Full Text] [Related]
40. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer.
Itzkowitz SH; Yuan M; Montgomery CK; Kjeldsen T; Takahashi HK; Bigbee WL; Kim YS
Cancer Res; 1989 Jan; 49(1):197-204. PubMed ID: 2908846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
